DSM To Axe 400 Jobs In Shake-Up To Lower Costs

Published: Dec 08, 2004

CHEMICALS group DSM is to shed 400 jobs as part of a reorganisation of the Dutch firm’s anti-infectives activities aimed at cutting costs by tens of millions of pounds. Plants in the Netherlands will be closed and production in China and India increased, the company confirmed in a statement. It has also decided to end its joint venture with GlaxoSmithKline in the UK for the production of penicillin-related product 6 APA. In addition, DSM plans to reduce its involvement in a joint venture in Mexico. DSM said it would give full financial details with its annual results in February. Of the 400 jobs, 250 will go in the Netherlands.

Back to news